Notably approximately 8% of non-small cell lung cancers (NSCLC) carry pathogenic mutations in NF1 (4), although most studies do not report the percentage of patients with complete inactivation of both alleles, which is probably lower. Here, NF1 is linked to non-small cell lung carcinoma.